This is a limited company view. Sign up for a Free Trial to see everything.

GlycoMimetics is a clinical-stage biotechnology company. We use novel and proprietary glycobiology technology to develop treatments for diseases particularly where there is high unmet need. Based on that technology, we have developed a robust, diversified product pipeline.

B2B
B2C
Biotechnology
Cleantech
Healthcare
Pharmaceuticals
Wind Power

Overview

Location

Rockville

Founded

2003

Employees

45

Stage

Public

Total funding

$38M

Last funding

8 years ago

Acquisitions

0

Growth score

111

Mindshare score

89

Scoring

Employee Growth

Use GlycoMimetics's historical employee count to better understand their growth and spending over time.

Unlock with a Free Trial

Mobile

Use GlycoMimetics's mobile downloads and app ranks to evaluate the performance of their mobile apps.

Unlock with a Free Trial

Key People

Clinical Project Manager
Sr. Clinical Project Manager
Director, Project Management
Clinical Supply Manager
Director of Chemistry
Senior Director, Clinical Development Programs Lead
Director, Corporate Contracts, Licensing and Business Development
Clinical Project Manager
Senior Director of Medicinal Chemistry
Research Assoc. 4
Research Associate IV
Sr. Accountant
Research Scientist III
Research Scientist III
Clinical Research Consultant
Scientist
Manager of Accounting
Research Scientist II

Similar Companies

DiaMedica Inc.

DiaMedica is a biopharmaceutical company focused on developing innovative treatments for stroke.
Pre-Series A|23 employees

Gain context with Mattermark Salesforce Enrichment

Find out how

Notes